University of Maryland School of Medicine, Maryland
Xiaofeng Jia, M.D., M.S., Ph.D., FCCM, is a Professor with Tenure in the Department of Neurosurgery, Orthopaedics, Anatomy & Neurobiology, the Director of the Neurosurgical Stem Cell Research, and the Director of Translational Neuroengineering and Neuroscience Laboratory at the University of Maryland School of Medicine, and the Adjunct Professor in the Department of Biomedical Engineering at Johns Hopkins University. He has been a faculty member at the Johns Hopkins University School of Medicine, Baltimore, MD, since 2007. His current research interests include brain monitoring and stem cell therapy, therapeutic hypothermia, peripheral nerve injury and regeneration, and stem cell therapy. Dr. Jia has been a PI on multiple grants from NIH, the U.S. Defense Advanced Research Projects Agency (DARPA), the American Association of Hand Surgery, the American Heart Association (AHA), and the Maryland Stem Cell Research Fund (MSCRF). He has published 159 peer-reviewed journal papers, with 90 of them as the first or corresponding author, and over 200 national /international conference publications/abstracts, including 169 platform presentations and invited talks. His research work was highlighted in NIH Research Matters and NIH 2015 Research Highlights (One of the total Eight selected), 2015. He is a recipient of the Society of Critical Care Medicine 2021, 2022, and 2023 Star Research Achievement Award. Dr. JIA is a fellow of the American College of Critical Care Medicine (FCCM). He has served as the Chair of the SCCM Research Section and a member of the Discovery Steering Committee and the Discovery Oversight Committee of the Society of Critical Care Medicine (SCCM). He is the Section Editor in Chief of the International Journal of Molecular Sciences (IJMS), Associate Editor of Frontiers in Immunology, and Frontiers in Neuroscience.
Metabolically Glycoengineered Stem Cell Therapy Improved Brain Recovery After Cardiac Arrest
Monday, March 23, 2026
9:00 AM - 10:00 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.